NET PROFIT (x1000 EUR)
EMPLOYEES
Biomedrex AB
Closing information (x1000 EUR)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
11
|
17
|
19 |
| Earnings before taxes |
28
|
33
|
-78 |
| EBITDA |
39
|
49
|
-58 |
| Total assets |
1,512
|
1,354
|
1,394 |
| Current assets |
4
|
17
|
100 |
| Current liabilities |
340
|
319
|
296 |
| Equity capital |
442
|
399
|
386 |
| - share capital |
4
|
4
|
5 |
| Employees (average) |
3
|
3
|
8 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
29.2%
|
29.5%
|
27.7% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
2.6%
|
3.7%
|
-4.2% |
| Current ratio |
1.2%
|
5.3%
|
33.8% |
| Return on equity (ROE) |
6.3%
|
8.3%
|
-20.2% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
-5
|
4 |
| Chg. No. of employees % |
0%
|
-63%
|
100% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.